FI824330A0 - 1- (3-NITROPHENYL) PYRIDO / 2,3-D / PYRIMIDINE-2,4 (1H, 3H) DIONER OCH 1- (3-NITROPHENYL) QUINAZOLINE-2,4 (1H, 3H) SAOSOM GENOM HUDEN VERKANDE - Google Patents

1- (3-NITROPHENYL) PYRIDO / 2,3-D / PYRIMIDINE-2,4 (1H, 3H) DIONER OCH 1- (3-NITROPHENYL) QUINAZOLINE-2,4 (1H, 3H) SAOSOM GENOM HUDEN VERKANDE

Info

Publication number
FI824330A0
FI824330A0 FI824330A FI824330A FI824330A0 FI 824330 A0 FI824330 A0 FI 824330A0 FI 824330 A FI824330 A FI 824330A FI 824330 A FI824330 A FI 824330A FI 824330 A0 FI824330 A0 FI 824330A0
Authority
FI
Finland
Prior art keywords
nitrophenyl
huden
dioner
verkande
saosom
Prior art date
Application number
FI824330A
Other languages
Finnish (fi)
Other versions
FI824330L (en
Inventor
Bernhard Pelster
Harald Horstmann
Original Assignee
Troponwerke Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troponwerke Gmbh & Co Kg filed Critical Troponwerke Gmbh & Co Kg
Publication of FI824330A0 publication Critical patent/FI824330A0/en
Publication of FI824330L publication Critical patent/FI824330L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

1. Cutaneously administrable medicament containing a compound of the general formula see diagramm : EP0082385,P7,F1 in which R denotes hydrogen, optionally unsaturated lower alkyl or aralkyl with in each case 1 to 20 carbon atoms, X denotes oxygen or sulphur and Y denotes nitrogen or CH, in the form of suppositories, suspensions, emulsions, sprays, powders, gels, ointments, pastes, creams and solutions, optionally in a microencapsulated from, but with the exception of tragacanth salt solutions.
FI824330A 1981-12-18 1982-12-16 1- (3-NITROPHENYL) PYRIDO / 2,3-D / PYRIMIDINE-2,4 (1H, 3H) DIONER OCH 1- (3-NITROPHENYL) QUINAZOLINE-2,4- (1H, 3H) DIONER SAOSOM GENOM HUDEN VERKANDE LAEKEMEDEL FI824330L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813150271 DE3150271A1 (en) 1981-12-18 1981-12-18 1- (3-NITROPHENYL) PYRIDO (2.3-D) PYRIMIDINE-2.4 (1H, 3H) -DIONE AND 1- (3-NITROPHENYL) CHINAZOLINE-2.4 (1H, 3H) -DIONE AS A CUTANE MEDICINAL PRODUCT

Publications (2)

Publication Number Publication Date
FI824330A0 true FI824330A0 (en) 1982-12-16
FI824330L FI824330L (en) 1983-06-19

Family

ID=6149136

Family Applications (1)

Application Number Title Priority Date Filing Date
FI824330A FI824330L (en) 1981-12-18 1982-12-16 1- (3-NITROPHENYL) PYRIDO / 2,3-D / PYRIMIDINE-2,4 (1H, 3H) DIONER OCH 1- (3-NITROPHENYL) QUINAZOLINE-2,4- (1H, 3H) DIONER SAOSOM GENOM HUDEN VERKANDE LAEKEMEDEL

Country Status (11)

Country Link
EP (1) EP0082385B1 (en)
JP (1) JPS58110518A (en)
AT (1) ATE21032T1 (en)
AU (1) AU9144682A (en)
CA (1) CA1201065A (en)
DE (2) DE3150271A1 (en)
FI (1) FI824330L (en)
GR (1) GR78419B (en)
NO (1) NO824044L (en)
PT (1) PT75957B (en)
ZA (1) ZA829268B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7064114B2 (en) 1999-03-19 2006-06-20 Parker Hughes Institute Gel-microemulsion formulations
AU3630100A (en) * 1999-03-19 2000-10-09 Parker Hughes Institute Quinazoline formulations and therapeutic use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016166A (en) * 1973-12-14 1977-04-05 Hisamitsu Pharmaceutical Co., Inc. 1-Nitrophenylquinazoline-2,4(1H,3H)-diones
JPS5649917B2 (en) * 1973-12-18 1981-11-25
EP0040793B1 (en) * 1980-05-22 1985-08-28 Masayuki Ishikawa Novel quinazoline-dione compounds, process for production thereof and pharmaceutical use thereof

Also Published As

Publication number Publication date
ATE21032T1 (en) 1986-08-15
NO824044L (en) 1983-06-20
FI824330L (en) 1983-06-19
JPS58110518A (en) 1983-07-01
CA1201065A (en) 1986-02-25
PT75957B (en) 1985-10-04
PT75957A (en) 1983-01-01
DE3150271A1 (en) 1983-06-30
GR78419B (en) 1984-09-27
EP0082385A1 (en) 1983-06-29
DE3272381D1 (en) 1986-09-04
EP0082385B1 (en) 1986-07-30
AU9144682A (en) 1983-06-23
ZA829268B (en) 1983-10-26

Similar Documents

Publication Publication Date Title
ES484626A1 (en) 5-Substituted 1-(2'-deoxy-2'-substituted-beta-D-arabinofuranosyl) pyrimidine nucleosides and pharmaceutical compositions containing them.
DK0654037T3 (en) Enantiomeric anti-retroviral nucleotide analogues
KR870006033A (en) Process for preparing pyridinyl pyrimidine derivative
FI824330A0 (en) 1- (3-NITROPHENYL) PYRIDO / 2,3-D / PYRIMIDINE-2,4 (1H, 3H) DIONER OCH 1- (3-NITROPHENYL) QUINAZOLINE-2,4 (1H, 3H) SAOSOM GENOM HUDEN VERKANDE
DE3376653D1 (en) Therapeutically active di-, tri-, tetra- and penta-aza indenes
KR850006410A (en) 1- [4-benzothia-or-oxazol-2-ylthio-or-2-yloxy) phenyl] -1,3,5-triazine-2,4,6- (1H, 3H, 5H) Trion manufacturing method
SE8203877L (en) AMINOSULFONYLBENSOESYRADERIVAT
MX9303990A (en) TETRAZOLIL (FENOXI AND FENOXIALQUIL) PIPERIDINIL PIRIDAZINAS AS ANTIVIRAL AGENTS.
DE3277373D1 (en) Process for preparing substituted pyrimidinones and intermediates therefor
ES8500895A1 (en) Pesticidal 1-(alkyl-phenoxyaryl)-3-benzoyl ureas and process for preparation.
DK552283D0 (en) CHEMICAL COMPOUNDS
IE780182L (en) N-9,10-DIHYDROLYSERGYL-m-AMINOBENZOIC ACID AMIDES.
GB1516753A (en) 2,4-diamino-5-benzylpyrimidines
GB1185039A (en) Pyrimidine Derivatives and Compositions containing them
ES8303400A1 (en) Benzylazole derivatives.
IL86665A0 (en) Mitomycin analogs
ATE54145T1 (en) AZAANTHRACEEN COMPOUNDS.
GB1173373A (en) Substituted 3-Aminopyrrolidines
DE3268244D1 (en) Process for the preparation of substituted pyrimidine

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: TROPONWERKE GMBH & CO. KG